Of particular interest here, activation of TGF-β signaling in tumor-reactive T cell acts as a potent inducer of exhaustion pathways via phosphorylation of SMAD2 and SMAD3 ahead of immune checkpoints. Here, TGFB1 is linked to neoplasm.